The best indicator for Synchrony Financial (SYF)
We backtested 20 indicators across daily, weekly and hourly charts on real Synchrony Financial (SYF) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
ADX / DMI
On the weekly chart, this is the strongest risk-adjusted edge we found for Synchrony Financial (SYF) over ~11.9 years — trailing buy-and-hold by 0.6% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | ADX / DMI ✓ | Weekly | 11.5% | 0.64 | -30.8% | 58.3% | 24 | -0.6% |
| 2 | MACD ✓ | Weekly | 12.9% | 0.63 | -29.3% | 39.1% | 23 | 0.8% |
| 3 | EMA 20/50 Cross ✓ | Daily | 10.6% | 0.54 | -53.7% | 39.1% | 23 | -1.6% |
| 4 | RSI Trend (>50) ✓ | Daily | 10.6% | 0.53 | -41.2% | 40.3% | 159 | -1.6% |
| 5 | EMA-10 Trend ✓ | Weekly | 10.0% | 0.51 | -41.3% | 44.0% | 50 | -2.1% |
| 6 | Donchian Midline ✓ | Weekly | 8.3% | 0.46 | -38.7% | 37.9% | 29 | -3.8% |
| 7 | Bollinger Breakout ✓ | Daily | 6.6% | 0.43 | -25.8% | 49.1% | 53 | -5.6% |
| 8 | Rate of Change ✓ | Daily | 7.7% | 0.42 | -34.1% | 51.0% | 194 | -4.4% |
| 9 | Donchian Midline ✓ | Daily | 6.9% | 0.39 | -44.2% | 40.6% | 165 | -5.3% |
| 10 | MACD ✓ | Daily | 6.2% | 0.37 | -51.5% | 41.5% | 123 | -6.0% |
| 11 | Williams %R ✓ | Daily | 4.1% | 0.29 | -65.0% | 68.8% | 77 | -8.1% |
| 12 | ADX / DMI ✓ | Daily | 3.5% | 0.28 | -40.3% | 42.5% | 80 | -8.7% |
| 13 | Bollinger Breakout ✓ | Weekly | 6.3% | 0.45 | -25.7% | 55.6% | 9 | -5.8% |
| 14 | Rate of Change ✓ | Weekly | 3.5% | 0.27 | -57.3% | 43.9% | 41 | -8.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Synchrony Financial (SYF), ADX / DMI on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.